Official Data: Yarrow Bioscience (YARW) Short Interest Update
Official FINRA-linked exchange reports for the mid-September settlement period show a massive influx of bearish positioning in Yarrow Bioscience. As of September 15, total short interest stood at 126,528 shares, representing a 123.9% increase from the 56,499 shares reported as of August 31.
While the absolute short interest remains at a moderate 4.9% of the total float, the rapid doubling of short positions suggests that institutional and retail sentiment has shifted aggressively following recent fundamental misses. With a short-interest ratio of 0.7 days, this move reflects a quick tactical pivot by bears rather than a long-term structural bet.
Key Takeaways
- SI Growth: +123.9% increase over 15 days.
- Current SI: 126,528 shares (4.9% of float).
- Context: Represents an aggressive tactical short build-up.
The Bottom Line
While Yarrow Bioscience is not yet a heavily crowded trade, the velocity at which new shorts are entering the position warrants close attention to price action near current support levels.
Signal data sourced from FINRA. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.